Investor Expectations to Drive Momentum within Gorman-Rupp, Mistras Group, Inovalon, Johnson Controls International plc, Best Buy Co., and Alliqua BioMedical — Discovering Underlying Factors of Influence

Author's Avatar
Jun 11, 2018
Article's Main Image

NEW YORK, June 11, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Gorman-Rupp Company (:GRC), Mistras Group Inc (:MG), Inovalon Holdings, Inc. (INOV, Financial), Johnson Controls International plc (:JCI), Best Buy Co., Inc. (:BBY), and Alliqua BioMedical, Inc. (ALQA, Financial), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

GRC DOWNLOAD: http://Fundamental-Markets.com/register/?so=GRC
MG DOWNLOAD: http://Fundamental-Markets.com/register/?so=MG
INOV DOWNLOAD: http://Fundamental-Markets.com/register/?so=INOV
JCI DOWNLOAD: http://Fundamental-Markets.com/register/?so=JCI
BBY DOWNLOAD: http://Fundamental-Markets.com/register/?so=BBY
ALQA DOWNLOAD: http://Fundamental-Markets.com/register/?so=ALQA

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine Gorman-Rupp Company (:GRC), Mistras Group Inc (:MG), Inovalon Holdings, Inc. (INOV, Financial), Johnson Controls International plc (:JCI), Best Buy Co., Inc. (:BBY), and Alliqua BioMedical, Inc. (ALQA, Financial) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed June 8th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

GORMAN-RUPP COMPANY (GRC, Financial) REPORT OVERVIEW

Gorman-Rupp's Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, Gorman-Rupp reported revenue of $96.60MM vs $92.60MM (up 4.32%) and basic earnings per share $0.37 vs $0.19 (up 94.74%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Gorman-Rupp reported revenue of $379.39MM vs $382.07MM (down 0.70%) and basic earnings per share $1.02 vs $0.95 (up 7.37%). Gorman-Rupp is expected to report earnings on July 27th, 2018. The report will be for the fiscal period ending June 30th, 2018.

To read the full Gorman-Rupp Company (GRC, Financial) report, download it here: http://Fundamental-Markets.com/register/?so=GRC

-----------------------------------------

MISTRAS GROUP INC (MG, Financial) REPORT OVERVIEW

Mistras Group's Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, Mistras Group reported revenue of $187.63MM vs $163.32MM (up 14.89%) and basic earnings per share $0.10 vs $0.06 (up 66.67%). Mistras Group is expected to report earnings on August 14th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $0.09. The estimated EPS forecast for the next fiscal year is $0.91 and is expected to report on March 11th, 2019.

To read the full Mistras Group Inc (MG, Financial) report, download it here: http://Fundamental-Markets.com/register/?so=MG

-----------------------------------------

INOVALON HOLDINGS, INC. (INOV, Financial) REPORT OVERVIEW

Inovalon's Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, Inovalon reported revenue of $92.76MM vs $108.31MM (down 14.36%) and basic earnings per share -$0.12 vs $0.02. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Inovalon reported revenue of $449.36MM vs $427.59MM (up 5.09%) and basic earnings per share $0.24 vs $0.18 (up 33.33%). Inovalon is expected to report earnings on August 1st, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $0.07. The estimated EPS forecast for the next fiscal year is $0.12 and is expected to report on February 19th, 2019.

To read the full Inovalon Holdings, Inc. (INOV, Financial) report, download it here: http://Fundamental-Markets.com/register/?so=INOV

-----------------------------------------

JOHNSON CONTROLS INTERNATIONAL PLC (JCI, Financial) REPORT OVERVIEW

Johnson Controls International plc's Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, Johnson Controls International plc reported revenue of $7,475.00MM vs $7,267.00MM (up 2.86%) and basic earnings per share $0.47 vs -$0.16. For the twelve months ended September 30th, 2017 vs September 30th, 2016, Johnson Controls International plc reported revenue of $30,172.00MM vs $20,837.00MM (up 44.80%) and basic earnings per share $1.72 vs -$1.30. Johnson Controls International plc is expected to report earnings on July 26th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $0.71. The estimated EPS forecast for the next fiscal year is $3.05 and is expected to report on November 8th, 2018.

To read the full Johnson Controls International plc (JCI, Financial) report, download it here: http://Fundamental-Markets.com/register/?so=JCI

-----------------------------------------

BEST BUY CO., INC. (BBY, Financial) REPORT OVERVIEW

Best Buy Co.'s Recent Financial Performance

For the three months ended April 30th, 2018 vs April 30th, 2017, Best Buy Co. reported revenue of $9,109.00MM vs $8,528.00MM (up 6.81%) and basic earnings per share $0.74 vs $0.61 (up 21.31%). For the twelve months ended January 31st, 2018 vs January 31st, 2017, Best Buy Co. reported revenue of $42,151.00MM vs $39,403.00MM (up 6.97%) and basic earnings per share $3.33 vs $3.86 (down 13.73%). Best Buy Co. is expected to report earnings on September 4th, 2018. The report will be for the fiscal period ending July 31st, 2018. The reported EPS for the same quarter last year was $0.69. The estimated EPS forecast for the next fiscal year is $5.43 and is expected to report on March 7th, 2019.

To read the full Best Buy Co., Inc. (BBY, Financial) report, download it here: http://Fundamental-Markets.com/register/?so=BBY

-----------------------------------------

ALLIQUA BIOMEDICAL, INC. (ALQA, Financial) REPORT OVERVIEW

Alliqua BioMedical's Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, Alliqua BioMedical reported revenue of $5.38MM vs $4.13MM (up 30.45%) and basic earnings per share -$1.19 vs -$2.27. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Alliqua BioMedical reported revenue of $19.57MM vs $16.29MM (up 20.07%) and basic earnings per share -$5.98 vs -$10.10. Alliqua BioMedical is expected to report earnings on June 12th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was -$1.90. The estimated EPS forecast for the next fiscal year is -$0.09 and is expected to report on March 1st, 2019.

To read the full Alliqua BioMedical, Inc. (ALQA, Financial) report, download it here: http://Fundamental-Markets.com/register/?so=ALQA

-----------------------------------------

ABOUT FUNDAMENTAL MARKETS

Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at [email protected].

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: [email protected]

© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at [email protected].

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.

ti?nf=NzMwMTM3OSMyMzYwMzkwIzUwMDAyNzg3MA==